Prescription weight loss drugs don't work for everyone
Be alert to gallbladder problems , which can occur with GLP-1 receptor agonists
DIABETES DRUG TESTED FOR WEIGHT LOSS COULD BE GAME CHANGER Jason Brett, executive director of Medical Affairs at Novo Nordisk Inc
NHS access is through specialist (Tier 3) weight management services, with eligibility based on NICE TA875 criteria
The prescribing clinician should be informed of any new symptoms, even if they seem unrelated to Wegovy, to ensure comprehensive safety monitoring
Many report noticeable changes within 24 weeks, depending on individual health conditions, lifestyle, and recovery demands